The Finnish company claims to be the world-leading innovator in the endometriosis field, with two active programs.

Its investors include Novo Seeds, Karolinska Development, Novartis Venture Fund, Vesalius Biocapital III Partners, M Ventures and Innovestor, along with  Sunstone Life Science Ventures.